Portfolio

Company Announcements

Director Declaration

Related Companies

RNS Number : 8229K
BTG PLC
21 April 2015
 



London, UK, 21 April 2015: Pursuant to Listing Rule 9.6.14R (2), BTG plc (LSE: BTG), the specialist healthcare company, announces that CEO Louise Makin was appointed as a non-executive director of Woodford Patient Capital Trust plc on 13 February 2015.  Woodford Patient Capital Trust plc was admitted to trading on the Main Market of the London Stock Exchange on 21 April 2015.

 

For further information contact:

 

BTG                                                                                                     FTI Consulting                                    

Andy Burrows, VP Corporate & Investor Relations                                                       Ben Atwell/Simon Conway

+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605                                                    +44 (0)20 3727 1000

 

Stuart Hunt, Investor Relations Manager

+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536

 

 

About BTG

BTG is a growing international specialist healthcare company bringing to market innovative products in specialist areas of medicine to better serve doctors and their patients. We have a portfolio of Interventional Medicine products to advance the treatment of liver tumours, severe blood clots, varicose veins and advanced emphysema, and Specialty Pharmaceuticals that help patients overexposed to certain medications or toxins. Inspired by patient and physician needs, BTG is investing to expand its portfolio to address some of today's most complex healthcare challenges. To learn more about BTG, please visit: www.btgplc.com

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNKMGZDNMGGKZG

Top of Page